However, the dire need for better non-invasive tests to determine prostate cancer is highlighted in meta-analyses of current procedures such as prostate specific antigen (PSA) tests and digital rectal examination, which provide little evidence that PSA tests have an impact on prostate cancer mortality [192]. This evidence concerns the gene KLK3 and prostate cancer.